Rheumatoid Arthritis: Key Updates on Guidelines, JAK Inhibitor Safety, and COVID-19 Considerations

To access the downloadable PowerPoint slide set, please click the download button.

Share

Program Content

  • Rheumatoid Arthritis: Key Updates on Guidelines, JAK Inhibitor Safety, and COVID-19 Considerations
    Rheumatoid Arthritis: Key Updates on Guidelines, JAK Inhibitor Safety, and COVID-19 Considerations
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022
    View Activity